Condition

Atrium clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Atrium clinical trials that are recruiting, at sites in 2 countries (most in United Kingdom (2), Brazil (1)). By phase: Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Atrium clinical trials

StudyPhaseWhereStatusRegistered
Comparing anticoagulants for patients with atrial fibrillation and severe kidney disease Phase 4 Salvador, Estado de Bahia and 5 other locations Recruiting May 7, 2024
Ablation and Isolation for Persistent Atrial Fibrillation Treatment — London Recruiting Dec 11, 2023
Personalized ablation strategies for atrial fibrillation — London Recruiting Dec 1, 2022

All recruiting trials (3)

Related topics

FibrillationAtrial ArrhythmiaAtrial Fibrillation, PersistentChronic Kidney DiseasesPersistent Atrial Fibrillation

Quick answers

How many Atrium clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in United Kingdom (2 trials), Brazil (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.